Clinical trials
Withdrawn Phase 1 Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Annick Desjardins | 1 |
| Center Trials & Treatment | 1 |
| City of Hope Medical Center | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Jeremy Rudnick, M.D | 1 |
| Jose Carrillo | 1 |
| Medical University of South Carolina | 1 |
| Michael Gunn | 1 |
| Michael Vogelbaum, MD, PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 18 |
| Glioblastoma | 8 |
| Astrocytoma | 4 |
| Brain Neoplasms | 4 |
| Ependymoma | 4 |
| Medulloblastoma | 3 |
| Gliosarcoma | 2 |
| Neuroectodermal Tumors, Primitive | 2 |
| Oligodendroglioma | 2 |
| Pinealoma | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.